Tower Wealth Partners, Inc.

Position in ABBV — AbbVie Inc.

CIK 1852808 LEWISBURG, PA

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$445,402

+$98,941 QoQ

Shares Held

1,770

+11.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.96%

of 13F equity value

Holder Rank

#3,274

of 4,153 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Tower Wealth Partners, Inc. holds $2,793,120 across 6 Drug Manufacturers - General names. ABBV ranks #4 (15.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,818	$715,687
2	MRK	Merck & Co., Inc.	4,683	$601,765
3	AMGN	Amgen Inc	1,333	$482,705
4	ABBV	AbbVie Inc. This page	1,770	$445,402
5	NVS	Novartis AG	2,192	$343,530
6	AZN	Astrazeneca PLC	1,076	$204,031

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$445,402	1,770	+11.1%	Shares	Sole	2026-08-12
2026-03-31	$346,461	1,593	+0.1%	Shares	Sole	2026-05-08
2025-12-31	$363,756	1,592	+1.5%	Shares	Sole	2026-01-16
2025-09-30	$363,286	1,569	+2.1%	Shares	Sole	2025-11-07
2025-06-30	$285,297	1,537	+3.4%	Shares	Sole	2025-07-28
2025-03-31	$311,346	1,486	+5.2%	Shares	Sole	2025-04-11
2024-12-31	$251,090	1,413	-0.9%	Shares	Sole	2025-02-07
2024-09-30	$281,606	1,426	+0.8%	Shares	Sole	2024-10-29
2024-06-30	$242,700	1,415	+16.0%	Shares	Sole	2024-08-09
2024-03-31	$222,162	1,220	—	Shares	Sole	2024-04-18
No filing history on record for this holder in this stock.